Gsk Debt-to-Equity Ratio Growth & History (GSK)

Gsk's debt-to-equity ratio was 0.93 for fiscal 2025.

View full Gsk company overview

Gsk annual debt-to-equity ratio history

Gsk annual debt-to-equity ratio

Fiscal yearPeriod endedDebt-to-equity ratioChangeGrowth
20252025-12-310.93−0.11−10.14%
20242024-12-311.04−0.18−14.69%
20232023-12-311.22−0.50−29.14%
20222022-12-311.720.33+24.02%
20212021-12-311.39−0.12−7.73%
20202020-12-311.50−0.73−32.74%
20192019-12-312.23−3.49−61.01%
20182018-12-315.72
20162016-12-3112.2811.07+916.43%
20152015-12-311.21

Gsk debt-to-equity ratio trends

Over the last five fiscal years, Gsk's debt-to-equity ratio decreased from 1.50 to 0.93, a change of −0.57. The latest reported quarter, Q2 2026, shows 1.03.

About the metric

What the debt-to-equity ratio means

The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.

Calculation and source

How debt-to-equity is calculated

TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Gsk source filings ↗

Community posts

It’s quiet here.

No posts about GSK yet. Start the conversation.

Write the first post